Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-24

Clinical Trial Update: Celecoxib (Celebrex) in the Management of Acute Renal Colic [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Celecoxib for acute renal colic due to ureteral calculi has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: University of Minnesota | Conditions: Ureteral Calculi | Phase 4 | Status: WITHDRAWN